touchMDT for touchONCOLOGY
Listen to a medical oncologist and a radiation oncologist discuss the importance of the initial assessment in NSCLC and the role of the different members of the multidisciplinary team.
The multidisciplinary team
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-navigating-diagnosis-and-treatment-nsclc/
